Tumour necrosis factor α concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function

Heart

Volumn 89, Issue 1, 2003, Pages 96-97

  Seiler, Christian ^a   Pohl, T ^a   Billinger, M ^a   Meier, B ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY STENOSIS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 0037223363     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-6.
2. Leibovich SJ, Polverini PJ, Shepard HM, et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329:630-2.
3. Yoshida A, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor and basic fibroblast growth factor in tumor necrosis factor-alpha, dependent angiogenesis. Molecular and Cellular Biology 1996;17:4015-23.
4. Seiler C, Fleisch M, Garachemani AR, et al. Coronary collateral quantitotion in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol 1998;32:1272-9.
5. Frater-Schröder M, Risau W, Hallmann R, et al. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci 1987;84:5277-81.